Loading...
•
Dec 31, 2023
Sabra Health Care REIT Q4 2023 Earnings Report
Sabra Health Care REIT reported Q4 2023 results, showing net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32.
Key Takeaways
Sabra Health Care REIT announced its Q4 2023 results, with key highlights including a net income of $0.07 per diluted common share, FFO of $0.30, Normalized FFO of $0.32, and AFFO of $0.32. The company expanded its relationship with Ignite Medical Resorts through the acquisition of two skilled nursing facilities. Sabra also introduced 2024 earnings guidance and declared a quarterly cash dividend of $0.30 per share of common stock.
Net Income was $0.07 per diluted common share.
FFO was $0.30 per diluted common share.
Normalized FFO was $0.32 per diluted common share.
AFFO was $0.32 per diluted common share.
Revenue by Segment
Forward Guidance
Sabra introduced 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted common share): Net Income: $0.53 - $0.57, FFO: $1.33 - $1.37, Normalized FFO: $1.34 - $1.38, AFFO: $1.38 - $1.42, Normalized AFFO: $1.39 - $1.43. Earnings guidance above assumes no 2024 acquisition or disposition activity.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...